Acadia Pharmaceuticals (ACAD) EBT Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Acadia Pharmaceuticals | 3.69 Bn | 2.84 Bn | 243.27 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 15.55% |
| Dec 31, 2025 | 19.10% |
| Sep 30, 2025 | 20.36% |
| Jun 30, 2025 | 24.26% |
| Mar 31, 2025 | 18.29% |
| Dec 31, 2024 | 38.30% |
| Sep 30, 2024 | 23.89% |
| Jun 30, 2024 | 21.81% |
| Mar 31, 2024 | 17.58% |
| Dec 31, 2023 | 21.11% |
| Sep 30, 2023 | 3.35% |
| Jun 30, 2023 | 16.00% |
| Mar 31, 2023 | 3.48% |
| Dec 31, 2022 | 9.93% |
| Sep 30, 2022 | 16.38% |
| Jun 30, 2022 | 12.92% |
| Mar 31, 2022 | -5.11% |
| Dec 31, 2021 | 11.12% |
| Sep 30, 2021 | 27.06% |
| Jun 30, 2021 | 9.46% |
| Mar 31, 2021 | -5.95% |
| Dec 31, 2020 | -24.96% |
| Sep 30, 2020 | -16.88% |
| Jun 30, 2020 | -1.18% |
| Mar 31, 2020 | -16.87% |
| Dec 31, 2019 | -29.02% |
| Sep 30, 2019 | -11.25% |
| Jun 30, 2019 | -20.48% |
| Mar 31, 2019 | -36.64% |
| Dec 31, 2018 | -47.18% |
| Sep 30, 2018 | -42.01% |
| Jun 30, 2018 | -47.34% |
| Mar 31, 2018 | -54.35% |
| Dec 31, 2017 | -58.86% |
| Sep 30, 2017 | -93.16% |
| Jun 30, 2017 | -65.38% |
| Mar 31, 2017 | -69.80% |
| Dec 31, 2016 | -70.94% |
| Sep 30, 2016 | -69.78% |
| Jun 30, 2016 | -61.18% |
| Mar 31, 2016 | -53.53% |
| Dec 31, 2015 | 16.80% |
| Sep 30, 2015 | -55.88% |